Follicular Lymphoma | Visiting Professors: Selection and Sequencing of Systemic Therapy in the Management of Follicular Lymphoma

published 1 week ago by Dr Neil Love

A presentation on follicular lymphoma featuring perspectives from Dr John P Leonard. Introduction Program Overview: Dr Leonard (00:00) Optimizing the Care of Patients with Newly Diagnosed Follicular Lymphoma (FL) Initiation of active therapy versus watchful waiting; indications for rituximab monotherapy (00:34) Choice of systemic therapy for patients requiring treatment; impact of age, tumor bulk and symptomatology (3:55) Clinical research data evaluating maintenance therapy; factors influencing its use (15:41) Data for and clinical role of subcutaneous rituximab (20:29) Management of Relapsed/Refractory (R/R) FL Factors affecting the sequencing of systemic therapy for R/R disease (eg, previous treatment received, remission duration, symptomatology) (22:37) Integration of obinutuzumab in the R/R setting (25:50) Role of lenalidomide/rituximab in the management of R/R FL (28:54) Available clinical research data with the FDA-approved PI3K inhibitors (34:41) CME information and select publications

more episodes from Research To Practice | Oncology Videos